CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.

CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.

Show other versions (1)

Castration-resistant prostate cancer (CRPC) is associated with resistance to androgen deprivation therapy, and an increase in the population of neuroendocrine (NE) differentiated cells. It is hypothesized that NE differentiated cells secrete neuropeptides that support androgen-independent tumor grow...

Full description

Bibliographic Details
Main Authors: Romie Angelo G Azur, Kevin Christian V Olarte, Weand S Ybañez, Alessandria Maeve M Ocampo, Pia D Bagamasbad
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0300413&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0300413&type=printable

Similar Items